Sports and exercise medicine clinic in public hospital settings: a real-life concept and experiences of the treatment of the first 1151 patients

被引:2
|
作者
Alanko, Lauri [1 ,2 ,3 ]
Laukkanen, Jari A. [4 ,5 ]
Rottensteiner, Mirva [2 ,3 ]
Rasmus, Salla [1 ,3 ]
Kuha, Tero [1 ]
Valtonen, Maarit [3 ]
Kujala, Urho M. [2 ]
机构
[1] Cent Finland Hlth Care Dist, Sports & Exercise Med Clin, Jyvaskyla, Finland
[2] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland
[3] Finnish Inst High Performance Sport KIHU, Jyvaskyla, Finland
[4] Univ Eastern Finland, Inst Clin Med, Dept Med, Kuopio, Finland
[5] Cent Finland Hlth Care Dist, Dept Med, Hoitajantie 3, Jyvaskyla 40620, Finland
关键词
Body composition cardiorespiratory fitness; exercise; physical activity; prevention; CARDIORESPIRATORY FITNESS; CHRONIC DISEASES; CAUSE MORTALITY; THERAPY; RISK;
D O I
10.1080/00325481.2022.2135894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Physical exercise has been shown to have a variety of health-promoting effects, including improvements in cardiorespiratory and muscular fitness, symptoms and risk factors such as LDL and HDL cholesterol, triglyceride and glycosylated hemoglobin concentrations. Regular physical exercise may slow down or even reverse the progression of various non-communicable diseases (NCDs). Despite the overwhelming evidence, physical exercise is not comprehensively used as a treatment component either in primary care or in hospital settings. Methods The outpatient Sports and Exercise Medicine Clinic (SEMC) is the first specialized clinic in Finland to use physical exercise as a part of the public health care system. Patients needing specialist attention due to NCDs, usually combined with sedentary lifestyles, are referred to the clinic. Results The prerequisites for patient referral are the known efficacy of physical exercise intervention in the treatment of disease and the need for sports and exercise medicine expertise. The focus of the clinic is to implement physical activity into daily life with other health-promoting habits such as diet, rest and the reduction of substance use. In addition, SEMC promotes the inclusion of physical exercise in several local treatment guidelines in the hospital district. The advisory treatment protocol of SEMC consists of a baseline evaluation, face-to-face visits with a physician and/or physiotherapist at 3, 6 and 9-12 months, and contacts via phone between hospital visits. Laboratory tests, body composition, walking tests, and measurements of muscle strength and balance are performed at baseline, and body composition and physical tests are repeated after 6 and 9-12 months. Conclusions At the core of the treatment is individualization, using motivational interviewing, considering the patients' personal interests and resources, and encouraging the patient to be an active member of our multi-professional team. We reported the first results in the SEMC with future development plans for the clinic.
引用
收藏
页码:283 / 289
页数:7
相关论文
共 10 条
  • [1] Comparison of thrombolytic agents in treatment of patients with acute ischemic stroke; findings from a single centre follow up study in real-life settings.
    George, Minu
    Baby, Neena
    Paul, Reji
    Zabeer, Mohammed
    Thomas, Chinchu
    JOURNAL OF CLINICAL NEUROSCIENCE, 2021, 91 : 299 - 305
  • [2] First-line treatment of chronic hepatitis B with entecavir or tenofovir in 'real-life' settings: from clinical trials to clinical practice
    Pol, S.
    Lampertico, P.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (06) : 377 - 386
  • [3] Atezolizumab in Patients with Metastatic Urothelial Carcinoma Who Have Progressed After First-line Chemotherapy: Results of Real-life Experiences
    Tural, Deniz
    Olmez, Omer Fatih
    Sumbul, Ahmet Taner
    Artac, Mehmet
    Ozhan, Nail
    Akar, Emre
    Cakar, Burcu
    Kostek, Osman
    Ekenel, Meltem
    Erman, Mustafa
    Coskun, Hasan Senol
    Selcukbiricik, Fatih
    Keskin, Ozge
    Turkoz, Fatma Paksoy
    Oruc, Kerem
    Bayram, Selami
    Yglmaz, Ugur
    Bilgetekin, Irem
    Ygldgz, Birol
    Sendur, Mehmet Ali Nahit
    Paksoy, Nail
    Dirican, Ahmet
    Erdem, Dilek
    Selam, Meltem
    Tanrgverdi, Ozgur
    Paydas, Semra
    Urakcg, Zuhat
    Atag, Elif
    Guncan, Sabri
    Urun, Yuksel
    Alkan, Ali
    Kaya, Ali Osman
    Ozyukseler, Deniz Tataroglu
    Taskaynatan, Halil
    Ygldgrgm, Mustafa
    Sonmez, Muge
    Basoglu, Tugba
    Gunduz, Seyda
    Kglgckap, Saadettin
    EUROPEAN UROLOGY FOCUS, 2021, 7 (05): : 1061 - 1066
  • [4] Evaluating the outcomes of Australia's first all-age public hospital Sport and Exercise Medicine Outpatient Clinic: a retrospective cross-sectional study
    Middleton, Dougal
    Thompson, Fintan
    James, Kira
    AUSTRALIAN HEALTH REVIEW, 2025, 49 (01)
  • [5] REAL-LIFE STUDY OF EFFICACY AND RESPONSE TO FIRST LINE TREATMENT IN PATIENTS WITH MULTIPLE MYELOMA CANDIDATES FOR TRANSPLANTATION. EXPERIENCE OF A CENTER
    Suarez Cabrera, A.
    Luzardo Henriquez, H.
    Gonzalvez, J.
    Perez, L.
    Guerra, L.
    Perera, M.
    Torres, M.
    Gomez Casares, M. T.
    Lemes, A.
    Gonzalez Perez, E.
    Saez Perdomo, M. N.
    Molero Labarta, T.
    Bravo de Laguna, Jimenez S.
    HAEMATOLOGICA, 2019, 104 : 20 - 20
  • [6] Analysis of real-life data on treatment quality in patients with exudative age-related-macular degeneration (AMD) and vein occlusion at a German university eye hospital
    Treder, M.
    Gaber, A.
    Rudloff, B.
    Eter, N.
    OPHTHALMOLOGE, 2019, 116 (06): : 553 - 562
  • [7] Clinical and economic impact of etanercept in real-life: A prospective, non-interventional study of etanercept in the treatment of patients with moderate to severe plaque psoriasis in private dermatologist settings (ESTHER)
    Larsen, Christian Gronhoj
    Andersen, Peter Hundevadt
    Lorentzen, Henrik
    Zachariae, Claus
    Huldt-Nystrom, Theis
    Dotterud, Lars Kare
    Lindkvist, Rose-Marie
    Qvitzau, Susanne
    EUROPEAN JOURNAL OF DERMATOLOGY, 2013, 23 (06) : 774 - 781
  • [8] Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEA
    Iannone, Florenzo
    Carlino, Giorgio
    Marchesoni, Antonio
    Sarzi-Puttini, Piercarlo
    Gorla, Roberto
    Lapadula, Giovanni
    JOINT BONE SPINE, 2016, 83 (06) : 721 - 725
  • [9] Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study
    Parisi, Alessandro
    Porzio, Giampiero
    Cannita, Katia
    Venditti, Olga
    Avallone, Antonio
    Filippi, Roberto
    Salvatore, Lisa
    Tortora, Giampaolo
    Ribelli, Marta
    Nigro, Olga
    Gelsomino, Fabio
    Spallanzani, Andrea
    Zurlo, Valeria
    Leo, Silvana
    Dell'Aquila, Emanuela
    Claudia, Fulgenzi
    Lombardi, Pasquale
    Keranen, Susana Rosello
    Aimar, Giacomo
    Depetris, Ilaria
    Giampieri, Riccardo
    Morelli, Cristina
    De Tursi, Michele
    Tinari, Nicola
    Di Pietro, Francesca Romana
    De Galitiis, Federica
    Zanaletti, Nicoletta
    Troiani, Teresa
    Vitale, Pasquale
    Garajova, Ingrid
    Ghidini, Michele
    Spinelli, Gian Paolo
    Zoratto, Federica
    Roberto, Michela
    Ierino, Debora
    Petrillo, Angelica
    D'Orazio, Carla
    Ficorella, Corrado
    Cortellini, Alessio
    CLINICAL COLORECTAL CANCER, 2021, 20 (04) : 318 - 325
  • [10] Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study
    Minari, Roberta
    Mazzaschi, Giulia
    Bordi, Paola
    Gnetti, Letizia
    Alberti, Giorgia
    Altimari, Annalisa
    Gruppioni, Elisa
    Sperandi, Francesca
    Parisi, Claudia
    Guaitoli, Giorgia
    Bettelli, Stefania
    Longo, Lucia
    Bertolini, Federica
    Pagano, Maria
    Bonelli, Candida
    Tagliavini, Elena
    Nicoli, Davide
    Ubiali, Alessandro
    Zangrandi, Adriano
    Trubini, Serena
    Proietto, Manuela
    Fiorentino, Michelangelo
    Tiseo, Marcello
    CLINICAL LUNG CANCER, 2020, 21 (05) : E464 - E473